Showing results (41-50 of 156) with videos related to
Sort By:
Pageof 16
Phlebology|March 23, 2022
Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatosesKurosh Parsi, Burcu Kim, Alicia A O'Connor, et al.Pathology|September 22, 2007
Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluationEmmanuel J Favaloro, Roslyn Bonar, Elizabeth Duncan, et al.Thrombosis and Haemostasis|June 30, 2006
Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluationEmmanuel J Favaloro, Roslyn Bonar, Elizabeth Duncan, et al.Blood Cell Therapy|August 18, 2023
Role of hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a report of 2 unique casesYadanar Lwin, David MaPhlebology|January 16, 2026
Formaldehyde is released from cyanoacrylate adhesives used in venous occlusion systemsJoseph Gracé, David E Connor, Richard O Day, et al.Journal of Vascular Surgery. Venous and Lymphatic Disorders|August 25, 2019
Angioscopy: Direct visualization of chronic venous occlusion, May-Thurner syndrome, and other applications in phlebologyMina Kang, Claudia Hurwitz, Tom Exner, et al.Frontiers in Genetics|June 14, 2021
Murine Blastocysts Release Mature MicroRNAs Into Culture Media That Reflect Developmental StatusDavid Connor Hawke, Danyal Baber Ahmed, Andrew John Watson, et al.Phlebology|October 15, 2016
Generation of sclerosant foams by mechanical methods increases the foam temperatureLulu Tan, Kaichung Wong, David Connor, et al.Experimental Biology and Medicine (Maywood, N.J.)|October 4, 2024
Development of a comprehensive open access "molecules with androgenic activity resource (MAAR)" to facilitate risk assessment of chemicalsFan Dong, Barry Hardy, Jie Liu, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 10, 2018
Integrated analysis of in vitro data and the adverse outcome pathway framework for prioritization and regulatory applications: An exploratory case study using publicly available data on piperonyl butoxide and liver modelsNoffisat O Oki, Lucian Farcal, Ahmed Abdelaziz, et al.Pageof 16